Skip to Content

Cellulosic Ethanol Inches Forward

The technology for making fuel from wood chips and grass is late, but still on the way.
March 13, 2013

A few years ago, large scale, billion-gallon-a-year cellulosic ethanol production seemed around the corner. Instead we’ve seen companies fail, or scale back and delay their plans, as they find it hard to secure financing or bring down costs. The technology seems to have dropped off the radar, except for the occasional news of opposition to a mandate requiring the use of cellulosic ethanol.

Still, there are signs of progress. This week ZeaChem announced it started production at a 250,000 gallon demonstration plant that is making chemicals that can be used to make ethanol and other things. Two companies, Ineos and Kior, have finished construction at larger plants that can produce 8 and 11 million gallons of fuel. They’re in the process of starting those plants up. And Poet and Abengoa hope to finish construction on even larger plants—25 million gallon ones-by the end of the year.

It’s still not clear that these companies can make ethanol profitably. ZeaChem is hedging its bets. It can make ethanol if that’s the most profitable option. Or it can convert the acetic acid it makes to chemicals such as propylene. Other advanced fuels companies, such as Amyris, are also pursuing chemicals at first.

But there are plenty of challenges involved in trying to break into existing chemical markets, especially if the chemicals are low-cost commodities. For example, chemicals like propylene are typically made by big petrochemical companies at huge well-integrated plants that make many chemicals, and have low costs that will be hard to compete with. 

Keep Reading

Most Popular

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.